Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation

Posaconazole (PCZ) is frequently used for prophylaxis against invasive fungal infections (IFI) in patients undergoing induction chemotherapy for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Posaconazole is commercially available as an oral suspension (PCZ-susp) and as a delayed-re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leuk Res Treatment
Main Authors: Belling, Morgan, Kanate, Abraham S., Shillingburg, Alexandra, Lu, Xiaoxiao, Wen, Sijin, Shah, Nilay, Craig, Michael, Cumpston, Aaron
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5485328/
https://ncbi.nlm.nih.gov/pubmed/28695013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/3460892
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados